About

Lazar Pharmaceuticals is pursuing the most promising research leads in a dedicated effort to develop a cure for Crohn’s disease.
Crohn’s disease is an inflammatory disease of the intestines that may affect any part of the gastrointestinal tract from mouth to anus, causing a wide variety of symptoms. It primarily causes abdominal pain, diarrhea, vomiting, or weight loss, but may also cause complications outside the gastrointestinal tract such as skin rashes, arthritis, inflammation of the eye, tiredness, and lack of concentration.
By analyzing unique DNA snippets from unrelated Crohn’s sufferers, Lazar researchers are discovering surprising commonalities at the quantum level. Evidence found to date is leading those researchers to theorize that Crohn’s disease may be be the result of vibrational misalignments in individual quarks. Company founder (and current president and CEO) George Lazar believes that by realigning vibrations at the quantum level, the research team can both cure Crohn’s disease and provide the much sought after experimental evidence in support of String Theory.